Oxford BioDynamics Plc (AIM:OBD)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.2600
-0.0050 (-1.89%)
At close: Dec 5, 2025

Oxford BioDynamics Revenue

Oxford BioDynamics had revenue of 587.00K GBP in the half year ending March 31, 2025, with 166.82% growth. This brings the company's revenue in the last twelve months to 896.00K, up 45.22% year-over-year. In the fiscal year ending September 30, 2024, Oxford BioDynamics had annual revenue of 636.00K with 24.71% growth.

Revenue (ttm)
896.00K
Revenue Growth
+45.22%
P/S Ratio
12.45
Revenue / Employee
20.36K
Employees
51
Market Cap
11.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024636.00K126.00K24.71%
Sep 30, 2023510.00K356.00K231.17%
Sep 30, 2022154.00K-187.00K-54.84%
Sep 30, 2021341.00K-115.00K-25.22%
Sep 30, 2020456.00K-451.00K-49.72%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.24B
GSK plc 32.17B
Haleon 11.02B
Smith & Nephew 4.33B
Convatec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Genus 672.80M
Revenue Rankings